Roxane Seeks To Nix 'Improperly Issued' AbbVie HIV Patent
Roxane Laboratories Inc. sued the U.S. Patent and Trademark Office last week, asking a federal judge to rule that an AbbVie Inc. HIV drug patent Roxane is accused of infringing is...To view the full article, register now.
Already a subscriber? Click here to view full article